UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment

Journal of pharmacological and toxicological methods, 2016-09, Vol.81, p.201-216

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson’s Disease

Neurochemical research, 2010-05, Vol.35 (5), p.761-772

2010

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of 1-Oxadecalins from Anisole Promoted by Tungsten

Journal of the American Chemical Society, 2008-09, Vol.130 (37), p.12472-12476

2008

Link zum Volltext

Verfügbarkeit prüfen

The Uncommon Reactivity of Dihapto-Coordinated Nitrile, Ketone, and Alkene Ligands When Bound to a Powerful π-Base

Organometallics, 2006-10, Vol.25 (21), p.5051-5058

2006

Link zum Volltext

Verfügbarkeit prüfen

The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin

The Journal of pharmacology and experimental therapeutics, 2002-01, Vol.300 (1), p.305

2002

Link zum Volltext

Verfügbarkeit prüfen

Large-Scale Syntheses of Several Synthons to the Dearomatization Agent {TpW(NO)(PMe3)} and Convenient Spectroscopic Tools for Product Analysis

Organometallics, 2007-05, Vol.26 (10), p.2791-2794

2007

Link zum Volltext

Verfügbarkeit prüfen

Discovery of 3-Substituted Aminocyclopentanes as Potent and Orally Bioavailable NR2B Subtype-Selective NMDA Antagonists

ACS chemical neuroscience, 2011-07, Vol.2 (7), p.352-362

2011

Link zum Volltext

Verfügbarkeit prüfen

Benzodiazepines as Potent and Selective Bradykinin B1 Antagonists

Journal of medicinal chemistry, 2003-05, Vol.46 (10), p.1803-1806

2003

Link zum Volltext

Verfügbarkeit prüfen

Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes

Journal of pharmacological and toxicological methods, 2016-09, Vol.81, p.217-222

2016

Link zum Volltext

Verfügbarkeit prüfen

Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav{sub 1.2} over-expressing cells

Toxicology and applied pharmacology, 2016-10, Vol.308

Lagrutta, Armando

2016

Link zum Volltext

Verfügbarkeit prüfen

Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells

Toxicology and applied pharmacology, 2016-10, Vol.308, p.66-76

2016

Link zum Volltext

Verfügbarkeit prüfen

Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model

The Journal of pharmacology and experimental therapeutics, 2004-08, Vol.310 (2), p.488

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 95: Pharmacological Characterization of Adenosine Effects on Spontaneously Beating Human-IPSC-Derived Cardiomyocytes

Circulation research, 2015-07, Vol.117 (suppl_1)

2015

Link zum Volltext

Verfügbarkeit prüfen

Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes

Biochemical and biophysical research communications, 1991-03, Vol.175 (2), p.556-561

1991

Link zum Volltext

Verfügbarkeit prüfen

Toward a Better Understanding of the Impedance Signal As an Indirect Measurement of Contractility in iCells/hiPSC-Derived Cardiomyocytes

Journal of pharmacological and toxicological methods, 2017-11, Vol.88, p.241-242

2017

Link zum Volltext

Verfügbarkeit prüfen

Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav 1.2 over-expressing cells

Toxicology and applied pharmacology, 2016-10, Vol.308, p.66-76

2016

Link zum Volltext

Verfügbarkeit prüfen

Group III Metabotropic Glutamate Receptor-Mediated Modulation of the Striatopallidal Synapse

The Journal of neuroscience, 2003-08, Vol.23 (18), p.7218-7226

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

European journal of pharmacology, 2014-04, Vol.728, p.31-38

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of the selective adenosine A sub(2A) receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

European journal of pharmacology, 2014-04, Vol.728, p.31-38

2014

Link zum Volltext

Verfügbarkeit prüfen

Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Journal of medicinal chemistry, 1998-06, Vol.41 (12), p.2146-2163

1998

Link zum Volltext

Verfügbarkeit prüfen

Stereoelectronic Effects in Dihapto-Coordinated Complexes of TpW(NO)(PMe3) and Their Manifestation in Diels−Alder Cycloaddition of Arenes

Organometallics, 2009-08, Vol.28 (16), p.4724-4734

2009

Link zum Volltext

Verfügbarkeit prüfen

Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency

Bioorganic & medicinal chemistry letters, 1999-05, Vol.9 (9), p.1311-1316

1999

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist

Life sciences (1973), 1996-03, Vol.58 (14), p.1149-1157

1996

Link zum Volltext

Verfügbarkeit prüfen

Benzodiazepines as Potent and Selective Bradykinin B 1 Antagonists

Journal of medicinal chemistry, 2003-05, Vol.46 (10), p.1803-1806

2003

Link zum Volltext

Verfügbarkeit prüfen

1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist

Journal of medicinal chemistry, 1995-11, Vol.38 (23), p.4634-4636

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(123)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment

Molecular Profiling of a 6-Hydroxydopamine Model of Parkinson’s Disease

Synthesis of 1-Oxadecalins from Anisole Promoted by Tungsten

The Uncommon Reactivity of Dihapto-Coordinated Nitrile, Ketone, and Alkene Ligands When Bound to a Powerful π-Base

The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin

Large-Scale Syntheses of Several Synthons to the Dearomatization Agent {TpW(NO)(PMe3)} and Convenient Spectroscopic Tools for Product Analysis

Discovery of 3-Substituted Aminocyclopentanes as Potent and Orally Bioavailable NR2B Subtype-Selective NMDA Antagonists

Benzodiazepines as Potent and Selective Bradykinin B1 Antagonists

Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes

Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav{sub 1.2} over-expressing cells

Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells

Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model

Abstract 95: Pharmacological Characterization of Adenosine Effects on Spontaneously Beating Human-IPSC-Derived Cardiomyocytes

Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypes

Toward a Better Understanding of the Impedance Signal As an Indirect Measurement of Contractility in iCells/hiPSC-Derived Cardiomyocytes

Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav 1.2 over-expressing cells

Group III Metabotropic Glutamate Receptor-Mediated Modulation of the Striatopallidal Synapse

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

Effects of the selective adenosine A sub(2A) receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Stereoelectronic Effects in Dihapto-Coordinated Complexes of TpW(NO)(PMe3) and Their Manifestation in Diels−Alder Cycloaddition of Arenes

Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potency

Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist

Benzodiazepines as Potent and Selective Bradykinin B 1 Antagonists

1-[1-[4-[(N-Acetyl-4-piperidinyl)oxy]-2- methoxybenzoyl]piperidin-4-yl]-4H-3,1- benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist

Suchergebnisse filtern